Skip to content

Drug interactions

Efavirenz + Fruquintinib

Severity: Moderate

Efavirenz and Fruquintinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz may lower fruquintinib exposure and reduce anticancer activity. Fruquintinib labeling discourages strong CYP3A inducers.

What this interaction means in plain words

Efavirenz and Fruquintinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Efavirenz belongs to Anti Virals; Fruquintinib belongs to Oncology.

Evidence level: Low

Why it happens

Efavirenz induces CYP3A4, which contributes to fruquintinib clearance.

What to do

Prefer a non-inducing antiretroviral. If coadministered, monitor tumour response and tolerability.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Efavirenz and Fruquintinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Efavirenz with Fruquintinib?

MediHelp rates the interaction as moderate. Efavirenz and Fruquintinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efavirenz may lower fruquintinib exposure and reduce anticancer activity. Fruquintinib labeling discourages strong CYP3A inducers.

How serious is the interaction between Efavirenz and Fruquintinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer a non-inducing antiretroviral. If coadministered, monitor tumour response and tolerability.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in